作者：
Russell, Richard J. [1]
;
Chachi, Latifa [2]
;
FitzGerald, J. Mark [3]
;
Backer, Vibeke [4]
;
Olivenstein, Ronald [5]
;
Titlestad, Ingrid L. [6]
;
Ulrik, Charlotte Suppli [7]
;
Harrison, Timothy [8]
;
Singh, Dave [9]
;
Chaudhuri, Rekha [10]
;
Leaker, Brian [11]
;
McGarvey, Lorcan [12]
;
Siddiqui, Salman [13]
;
Wang, Millie [14]
;
Braddock, Martin [15]
;
Nordenmark, Lars H. ;
Cohen, David ;
Parikh, Himanshu ;
Colice, Gene ;
Brightling, Christopher E.
作者单位：
Hvidovre Univ Hosp, Dept Resp Med, Hvidovre, Denmark
[1]
AstraZeneca, Resp Global Med Dev, Cambridge, England
[2]
Univ Copenhagen, Bispebjerg Hosp, Dept Resp Med, Copenhagen, Denmark
[3]
Queens Univ Belfast, Ctr Expt Med, Belfast, Antrim, North Ireland
[4]
McGill Univ, Resp Div, Dept Med, Hlth Ctr, Montreal, PQ, Canada
[5]
Queen Anne St Med Ctr, Resp Clin Trials, London, England
[6]
Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[7]
Odense Univ Hosp, Dept Resp Med, Odense, Denmark
[8]
AstraZeneca, Resp Global Med Dev, Mississauga, ON, Canada
[9]
Univ British Columbia, Inst Heart & Lung Hlth, Vancouver, BC, Canada
[10]
Univ Nottingham, NIHR Resp Biomed Res Ctr, Nottingham, England
[11]
AstraZeneca, Resp Global Med Dev, Gothenburg, Sweden
[12]
Gartnavel Royal Hosp, Resp Med Dept, Glasgow, Lanark, Scotland
[13]
Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[14]
AstraZeneca, Resp Global Med Dev, Gaithersburg, MD USA
[15]
发布时间
2018-08-30
换一批
换一批
